Mehdi Tafti

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


143 publications

Sous presse | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 |
 
Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment.
Bassetti CLA, Adamantidis A., Burdakov D., Han F., Gay S., Kallweit U., Khatami R., Koning F., Kornum B.R., Lammers G.J. et al. Nature reviews. Neurology. Peer-reviewed.
 
Molecular codes and in vitro generation of hypocretin and melanin concentrating hormone neurons.
Seifinejad A., Li S., Mikhail C., Vassalli A., Pradervand S., Arribat Y., Pezeshgi Modarres H., Allen B., John R.M., Amati F. et al. Proceedings of the National Academy of Sciences of the United States of America. Peer-reviewed.
 
Kleine-Levin syndrome is associated with LMOD3 variants.
Al Shareef S.M., Basit S., Li S., Pfister C., Pradervand S., Lecendreux M., Mayer G., Dauvilliers Y., Salpietro V., Houlden H. et al., 2019/06. Journal of sleep research, 28 (3) pp. e12718. Peer-reviewed.
 
Sleep modulates haematopoiesis and protects against atherosclerosis.
McAlpine C.S., Kiss M.G., Rattik S., He S., Vassalli A., Valet C., Anzai A., Chan C.T., Mindur J.E., Kahles F. et al., 2019/02. Nature, 566 (7744) pp. 383-387. Peer-reviewed.
 
T cells in patients with narcolepsy target self-antigens of hypocretin neurons.
Latorre D., Kallweit U., Armentani E., Foglierini M., Mele F., Cassotta A., Jovic S., Jarrossay D., Mathis J., Zellini F. et al., 2018/10. Nature, 562 (7725) pp. 63-68. Peer-reviewed.
In vitro Cortical Network Firing is Homeostatically Regulated: A Model for Sleep Regulation.
Saberi-Moghadam S., Simi A., Setareh H., Mikhail C., Tafti M., 2018. Scientific Reports, 8 (1) p. 6297. Peer-reviewed.
Lauflumide (NLS-4) Is a New Potent Wake-Promoting Compound.
Luca G., Bandarabadi M., Konofal E., Lecendreux M., Ferrié L., Figadère B., Tafti M., 2018. Frontiers in neuroscience, 12 p. 519. Peer-reviewed.
Cerebral mGluR5 availability contributes to elevated sleep need and behavioral adjustment after sleep deprivation.
Holst S.C., Sousek A., Hefti K., Saberi-Moghadam S., Buck A., Ametamey S.M., Scheidegger M., Franken P., Henning A., Seifritz E. et al., 2017/10/05. eLife, 6 pp. eLife.28751. Peer-reviewed.
 
Rare missense mutations in P2RY11 in narcolepsy with cataplexy.
Degn M., Dauvilliers Y., Dreisig K., Lopez R., Pfister C., Pradervand S., Rahbek Kornum B., Tafti M., 2017/06/01. Brain, 140 (6) pp. 1657-1668. Peer-reviewed.
 
Measurement of narcolepsy symptoms: The Narcolepsy Severity Scale.
Dauvilliers Y., Beziat S., Pesenti C., Lopez R., Barateau L., Carlander B., Luca G., Tafti M., Morin C.M., Billiard M. et al., 2017/04/04. Neurology, 88 (14) pp. 1358-1365. Peer-reviewed.
 
Sleep characteristics and cognitive impairment in the general population: The HypnoLaus study.
Haba-Rubio J., Marti-Soler H., Tobback N., Andries D., Marques-Vidal P., Waeber G., Vollenweider P., von Gunten A., Preisig M., Castelao E. et al., 2017/01/31. Neurology, 88 (5) pp. 463-469. Peer-reviewed.
ERK signaling pathway regulates sleep duration through activity-induced gene expression during wakefulness.
Mikhail C., Vaucher A., Jimenez S., Tafti M., 2017/01/24. Science signaling, 10 (463) p. 463. Peer-reviewed.
 
The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study.
Marti-Soler H., Hirotsu C., Marques-Vidal P., Vollenweider P., Waeber G., Preisig M., Tafti M., Tufik S.B., Bittencourt L., Tufik S. et al., 2016/09. The Lancet. Respiratory medicine, 4 (9) pp. 742-748. Peer-reviewed.
 
Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity.
Tafti M., Lammers G.J., Dauvilliers Y., Overeem S., Mayer G., Nowak J., Pfister C., Dubois V., Eliaou J.F., Eberhard H.P. et al., 2016. Sleep, 39 (3) pp. 581-587. Peer-reviewed.
Prevalence and determinants of periodic limb movements in the general population.
Haba-Rubio J., Marti-Soler H., Marques-Vidal P., Tobback N., Andries D., Preisig M., Waeber G., Vollenweider P., Kutalik Z., Tafti M. et al., 2016. Annals of Neurology, 79 (3) pp. 464-474. Peer-reviewed.
 
Sleep Characteristics in Early Stages of Chronic Kidney Disease in the HypnoLaus Cohort.
Ogna A., Forni Ogna V., Haba Rubio J., Tobback N., Andries D., Preisig M., Tafti M., Vollenweider P., Waeber G., Marques-Vidal P. et al., 2016. Sleep, 39 (4) pp. 945-953. Peer-reviewed.
 
The European Narcolepsy Network (EU-NN) database.
Khatami R., Luca G., Baumann C.R., Bassetti C.L., Bruni O., Canellas F., Dauvilliers Y., Del Rio-Villegas R., Feketeova E., Ferri R. et al., 2016. Journal of Sleep Research, 25 (3) pp. 356-364. Peer-reviewed.
 
Age and gender variations of sleep in subjects without sleep disorders.
Luca G., Haba Rubio J., Andries D., Tobback N., Vollenweider P., Waeber G., Marques Vidal P., Preisig M., Heinzer R., Tafti M., 2015. Annals of Medicine, 47 (6) pp. 482-491.
 
Association of socioeconomic status with sleep disturbances in the Swiss population-based CoLaus study.
Stringhini S., Haba-Rubio J., Marques-Vidal P., Waeber G., Preisig M., Guessous I., Bovet P., Vollenweider P., Tafti M., Heinzer R., 2015. Sleep Medicine, 16 (4) pp. 469-476. Peer-reviewed.
 
Bad sleep? Don't blame the moon! A population-based study.
Haba-Rubio J., Marques-Vidal P., Tobback N., Andries D., Preisig M., Kuehner C., Vollenweider P., Waeber G., Luca G., Tafti M. et al., 2015. Sleep Medicine, 16 (11) pp. 1321-1326. Peer-reviewed.
 
Catechol-O-methyltransferase, dopamine, and sleep-wake regulation.
Dauvilliers Y., Tafti M., Landolt H.P., 2015. Sleep Medicine Reviews, 22 pp. 47-53. Peer-reviewed.
 
Central and peripheral metabolic changes induced by gamma-hydroxybutyrate.
Luca G., Vienne J., Vaucher A., Jimenez S., Tafti M., 2015. Sleep, 38 (2) pp. 305-313.
Comment on "Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2".
Vassalli A., Li S., Tafti M., 2015. Science Translational Medicine, 7 (314) pp. 314le2. Peer-reviewed.
 
Cytokine-induced sleep: Neurons respond to TNF with production of chemokines and increased expression of Homer1a in vitro.
Karrer M., Lopez M.A., Meier D., Mikhail C., Ogunshola O.O., Müller A.F., Strauss L., Tafti M., Fontana A., 2015. Brain, Behavior, and Immunity, 47 (6) pp. 186-192. Peer-reviewed.
 
Effect of transnasal insufflation on sleep-disordered breathing in acute stroke.
Haba-Rubio J., Andries D., Rey-Bataillard V., Michel P., Tafti M., Heinzer R., 2015. Sleep and Breathing, 19 (1) p. 3.
 
HLA-DQ Allele Competition in Narcolepsy: Where is the Evidence?
Tafti M., 2015. Sleep, 38 (1) pp. 153-154.
 
Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy.
Liblau R.S., Vassalli A., Seifinejad A., Tafti M., 2015. Lancet. Neurology, 14 (3) pp. 318-328.
 
Neurology and psychiatry: waking up to opportunities of sleep. : State of the art and clinical/research priorities for the next decade.
Bassetti C.L., Ferini-Strambi L., Brown S., Adamantidis A., Benedetti F., Bruni O., Cajochen C., Dolenc-Groselj L., Ferri R., Gais S. et al., 2015. European Journal of Neurology, 22 (10) pp. 1337-1354. Peer-reviewed.
Objective Sleep Structure and Cardiovascular Risk Factors in the General Population: The HypnoLaus Study.
Haba-Rubio J., Marques-Vidal P., Andries D., Tobback N., Preisig M., Vollenweider P., Waeber G., Luca G., Tafti M., Heinzer R., 2015. Sleep, 38 (3) pp. 391-400. Peer-reviewed.
Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study.
Heinzer R., Vat S., Marques-Vidal P., Marti-Soler H., Andries D., Tobback N., Mooser V., Preisig M., Malhotra A., Waeber G. et al., 2015. Lancet. Respiratory Medicine, 3 (4) pp. 310-318. Peer-reviewed.
 
Scoring criteria for portable monitor recordings: a comparison of four hypopnoea definitions in a population-based cohort.
Vat S., Haba-Rubio J., Tafti M., Tobback N., Andries D., Heinzer R., 2015. Thorax, 70 (11) pp. 1047-1053.
 
Prevalence and characteristics of periodic leg movements during sleep in the general population : the Hypnolaus study
Haba-Rubio J., Marti-Soler H., Andries D., Tobback N. M., Tafti M., Heinzer R., 2014/09. p. 226 dans 22nd Congress of the European Sleep Research Society, 16-20 September 2014, Tallinn, Estonia. Peer-reviewed.
 
Sleep structure and cardiometabolic disorders in the general population : the Hypnolaus study
Haba-Rubio J., Marques-Vidal P., Andries D., Tobback N., Tafti M., Heinzer R., Marques-Vidal P., Waeber G., Preisig M., Vollenweider P. et al., 2014/09. p. 151 dans 22nd Congress of the European-Sleep-Research-Society, Tallinn, Estonia, SEP 16-20, 2014. Peer-reviewed.
 
DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe.
Tafti M., Hor H., Dauvilliers Y., Lammers G.J., Overeem S., Mayer G., Javidi S., Iranzo A., Santamaria J., Peraita-Adrados R. et al., 2014. Sleep, 37 (1) pp. 19-25.
Novel Approach Identifies SNPs in SLC2A10 and KCNK9 with Evidence for Parent-of-Origin Effect on Body Mass Index.
Hoggart C.J., Venturini G., Mangino M., Gomez F., Ascari G., Zhao J.H., Teumer A., Winkler T.W., Ternikova N., Luan J. et al., 2014. PLoS Genetics, 10 (7) pp. e1004508.
 
A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms?
Peraita-Adrados R., Lammers G.J., De Andrés C., Santamaría J., Vicario J.L., Tafti M., 2013. Sleep Medicine, 14 (7) pp. 695-696.
 
Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study.
Luca G., Haba-Rubio J., Dauvilliers Y., Lammers G.J., Overeem S., Donjacour C.E., Mayer G., Javidi S., Iranzo A., Santamaria J. et al., 2013. Journal of Sleep Research, 22 (5) pp. 482-495.
Electroencephalogram paroxysmal theta characterizes cataplexy in mice and children.
Vassalli A., Dellepiane J.M., Emmenegger Y., Jimenez S., Vandi S., Plazzi G., Franken P., Tafti M., 2013. Brain, 136 (Pt 5) pp. 1592-1608.
 
Genetics of recurrent hypersomnia
Billiard M., Peraita-Adrados R., Tafti M., 2013. pp. 272-277 dans Shaw P., Tafti M., Thorpy M.J. (eds.) The Genetic Basis of Sleep and Sleep Disorders chap. 27, Cambridge University Press.
 
Genetics of sleep and EEG
Curie T., Tafti M., 2013. pp. 139-146 dans Shaw P., Tafti M., Thorpy M.J. (eds.) The Genetic Basis of Sleep and Sleep Disorders chap. 14, Cambridge University Press.
 
Age-related changes in sleep in inbred mice are genotype dependent.
Hasan S., Dauvilliers Y., Mongrain V., Franken P., Tafti M., 2012. Neurobiology of Aging, 33 (1) pp. 195.e13-195.e26.
Blood pressure increases with sleep disordered breathing severity in the general population: the HypnoLaus study
Haba-Rubio J., Andries D., Tobback N., Vaucher J., Marques-Vidal P., Vollenweider P., Waeber G., Tafti M., Heinzer RC., 2012. pp. A316 dans Sleep 2012, 26th Annual Meeting of the Associated Professional Sleep Society, Sleep.
 
Differential effects of sodium oxybate and baclofen on EEG, sleep, neurobehavioral performance, and memory.
Vienne J., Lecciso G., Constantinescu I., Schwartz S., Franken P., Heinzer R., Tafti M., 2012. Sleep, 35 (8) pp. 1071-1083.
 
Dreaming without REM sleep.
Oudiette D., Dealberto M.J., Uguccioni G., Golmard J.L., Merino-Andreu M., Tafti M., Garma L., Schwartz S., Arnulf I., 2012. Consciousness and Cognition, 21 (3) pp. 1129-1140. Peer-reviewed.
 
Effect of transnasal insufflation on sleep disordered breathing in acute stroke: a preliminary study.
Haba-Rubio J., Andries D., Rey V., Michel P., Tafti M., Heinzer R., 2012. Sleep and Breathing, 16 (3) pp. 759-764. Peer-reviewed.
Key electrophysiological, molecular, and metabolic signatures of sleep and wakefulness revealed in primary cortical cultures.
Hinard V., Mikhail C., Pradervand S., Curie T., Houtkooper R.H., Auwerx J., Franken P., Tafti M., 2012. Journal of Neuroscience, 32 (36) pp. 12506-12517.
 
Kleine-Levin syndrome: Functional imaging correlates of hypersomnia and behavioral symptoms.
Haba-Rubio J., Prior J.O., Guedj E., Tafti M., Heinzer R., Rossetti A.O., 2012. Neurology, 79 (18) pp. 1927-1929.
 
Monozygotic twins affected with Kleine-Levin syndrome.
Peraita-Adrados R., Vicario J.L., Tafti M., García de León M., Billiard M., 2012. Sleep, 35 (5) pp. 595-596.
 
Positional therapy for obstructive sleep apnea: an objective measurement of patients' usage and efficacy at home.
Heinzer R.C., Pellaton C., Rey V., Rossetti A.O., Lecciso G., Haba-Rubio J., Tafti M., Lavigne G., 2012. Sleep Medicine, 13 (4) pp. 425-428. Peer-reviewed.
Prevalence of diabetes increases with sleep disordered breathing severity in the general population: the HypnoLaus study
Haba-Rubio J., Andries D., Tobback N., Vaucher J., Marques-Vidal P., Vollenweider P., Waeber G., Tafti M., Heinzer R.C., 2012. pp. A293-A294 dans Sleep 2012, 26th Annual Meeting of the Associated Professional Sleep Society, Sleep.
 
Sleep and genetics
Franken P., Tafti P., 2012. pp. 43-45 dans Bassetti C.L., Knobl B., Schulz H (eds.) European Sleep Research Society, 1972-2012, European Sleep Research Society.
 
HypnoLaus: le sommeil sous la loupe [HypnoLaus sleep cohort study].
Heinzer R., Haba-Rubio J., Tafti M., 2011/11. Revue Médicale Suisse, 7 (315) pp. 2137-2141.
 
A missense mutation in myelin oligodendrocyte glycoprotein as a cause of familial narcolepsy with cataplexy.
Hor H., Bartesaghi L., Kutalik Z., Vicário J.L., de Andrés C., Pfister C., Lammers G.J., Guex N., Chrast R., Tafti M. et al., 2011. American Journal of Human Genetics, 89 (3) pp. 474-479.
 
Improvement of migraine headaches in severely obese patients after bariatric surgery.
Haba-Rubio J., Tafti M., Heinzer R., Bond D.S., Wing R.R., 2011. Neurology, 77 (19) pp. 1772-3; author reply 1773.
 
Narcolepsie avec cataplexie après vaccination anti-H1N1
Haba-Rubio J., Rossetti A.O., Tafti M., Heinzer R., 2011. Revue Neurologique, 167 (8-9) pp. 563-566.
 
Source inference of exogenous gamma-hydroxybutyric acid (GHB) administered to humans by means of carbon isotopic ratio analysis: novel perspectives regarding forensic investigation and intelligence issues.
Marclay F., Saudan C., Vienne J., Tafti M., Saugy M., 2011. Analytical and Bioanalytical Chemistry, 400 (4) pp. 1105-1112.
Differential effects of GABAB receptor subtypes, {gamma}-hydroxybutyric Acid, and Baclofen on EEG activity and sleep regulation.
Vienne J., Bettler B., Franken P., Tafti M., 2010/10/20. The Journal of neuroscience : the official journal of the Society for Neuroscience, 30 (42) pp. 14194-14204. Peer-reviewed.
 
Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients.
Cvetkovic-Lopes V., Bayer L., Dorsaz S., Maret S., Pradervand S., Dauvilliers Y., Lecendreux M., Lammers G.J., Donjacour C.E., Du Pasquier R.A. et al., 2010. Journal of Clinical Investigation, 120 (3) pp. 713-719. Peer-reviewed.
 
Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy.
Hor H., Kutalik Z., Dauvilliers Y., Valsesia A., Lammers G.J., Donjacour C.E., Iranzo A., Santamaria J., Peraita Adrados R., Vicario J.L. et al., 2010. Nature Genetics, 42 (9) pp. 786-789.
 
Pulse Wave Amplitude Drops during Sleep are Reliable Surrogate Markers of Changes in Cortical Activity.
Delessert A., Espa F., Rossetti A., Lavigne G., Tafti M., Heinzer R., 2010. Sleep, 33 (12) pp. 1687-1692. Peer-reviewed.
 
Rapid occurrence of depression following addition of sodium oxybate to modafinil.
Rossetti A.O., Heinzer R.C., Tafti M., Buclin T., 2010. Sleep Medicine, 11 (5) pp. 500-501. Peer-reviewed.
 
Sodium oxybate is an effective and safe treatment for narcolepsy.
Lammers G.J., Bassetti C., Billiard M., Black J., Broughton R., Dauvilliers Y., Ferini Strambi L., Garcia-Borreguero D., Goswami M., Högl B. et al., 2010. Sleep Medicine, 11 (1) pp. 105-106; author reply 106-108.
 
Genetic aspects of normal and disturbed sleep.
Tafti M., 2009. Sleep Medicine, 10 Suppl 1 pp. S17-S21.
 
How to keep the brain awake? The complex molecular pharmacogenetics of wake promotion.
Hasan S., Pradervand S., Ahnaou A., Drinkenburg W., Tafti M., Franken P., 2009. Neuropsychopharmacology, 34 (7) pp. 1625-1640. Peer-reviewed.
 
Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment.
Dauvilliers Y., Abril B., Mas E., Michel F., Tafti M., 2009. Neurology, 73 (16) pp. 1333-1334.
 
Physiology. How much sleep do we need?
Hor H., Tafti M., 2009. Science, 325 (5942) pp. 825-826.
 
Drops in pulse wave amplitude, a micro-arousal scoring surrogate
Delessert A., Espa F., Rossetti A., Lavigne G., Tafti M., Heinzer R., 2008. pp. 20S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
 
Genetics of sleep.
Andretic R., Franken P., Tafti M., 2008. Annual Review of Genetics, 42 pp. 361-388. Peer-reviewed.
 
The genetic basis of sleep disorders.
Dauvilliers Y., Tafti M., 2008. Current Pharmaceutical Design, 14 (32) pp. 3386-3395. Peer-reviewed.
 
Unilateral periodic leg movements during wakefulness and sleep after a parietal hemorrhage.
Rossetti A.O., Heinzer R., Espa F., Tafti M., 2008. Sleep Medicine, 9 (4) pp. 465-466.
 
Functional implication of the vitamin A signaling pathway in the brain.
Tafti M., Ghyselinck N.B., 2007. Archives of Neurology, 64 (12) pp. 1706-1711. Peer-reviewed.
 
Homer1a is a core brain molecular correlate of sleep loss.
Maret S., Dorsaz S., Gurcel L., Pradervand S., Petit B., Pfister C., Hagenbuchle O., O'Hara B.F., Franken P., Tafti M., 2007. Proceedings of the National Academy of Sciences of the United States of America, 104 (50) pp. 20090-20095. Peer-reviewed.
 
Molecular analysis of sleep.
Tafti M., Franken P., 2007. Cold Spring Harbor Symposia on Quantitative Biology, 72 pp. 573-578. Peer-reviewed.
 
Narcolepsy and familial advanced sleep-phase syndrome: molecular genetics of sleep disorders.
Tafti M., Dauvilliers Y., Overeem S., 2007. Current Opinion in Genetics and Development, 17 (3) pp. 222-227. Peer-reviewed.
Quantitative genetics of sleep in inbred mice.
Tafti M., 2007. Dialogues in Clinical Neuroscience, 9 (3) pp. 273-278. Peer-reviewed.
 
Reply to 'Promotion of sleep by targeting the orexin system in rats, dogs and humans'.
Tafti M., 2007. Nature Medicine, 13 (5) pp. 525-6; author reply 526.
 
Daytime sleepiness and the COMT val158met polymorphism in patients with Parkinson disease.
Rissling I., Frauscher B., Kronenberg F., Tafti M., Stiasny-Kolster K., Robyr A.C., Körner Y., Oertel W.H., Poewe W., Högl B. et al., 2006. Sleep, 29 (1) pp. 108-111. Peer-reviewed.
 
Daytime sleepiness with and without cataplexy in Chinese-Taiwanese patients.
Huang Y.S., Tafti M., Guilleminault C., 2006. Sleep Medicine, 7 (5) pp. 454-457. Peer-reviewed.
 
Molecular genetics and treatment of narcolepsy.
Dauvilliers Y., Tafti M., 2006. Annals of Medicine, 38 (4) pp. 252-262. Peer-reviewed.
 
Sleep EEG changes after middle cerebral artery infarcts in mice: different effects of striatal and cortical lesions.
Baumann C.R., Kilic E., Petit B., Werth E., Hermann D.M., Tafti M., Bassetti C.L., 2006. Sleep, 29 (10) pp. 1339-1344. Peer-reviewed.
 
Genes for normal sleep and sleep disorders.
Tafti M., Maret S., Dauvilliers Y., 2005. Annals of Medicine, 37 (8) pp. 580-589. Peer-reviewed.
Genetics of narcolepsy and other major sleep disorders.
Maret S., Tafti M., 2005. Swiss Medical Weekly, 135 (45-46) pp. 662-665.
 
Genetics of normal and pathological sleep in humans.
Dauvilliers Y., Maret S., Tafti M., 2005. Sleep Medicine Reviews, 9 (2) pp. 91-100. Peer-reviewed.
 
Retinoic acid signaling affects cortical synchrony during sleep.
Maret S., Franken P., Dauvilliers Y., Ghyselinck N.B., Chambon P., Tafti M., 2005. Science, 310 (5745) pp. 111-113.
 
A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1.
Dauvilliers Y., Maret S., Bassetti C., Carlander B., Billiard M., Touchon J., Tafti M., 2004. Neurology, 62 (11) pp. 2137-2138. Peer-reviewed.
 
A narcolepsy susceptibility locus maps to a 5 Mb region of chromosome 21q.
Dauvilliers Y., Blouin J.L., Neidhart E., Carlander B., Eliaou J.F., Antonarakis S.E., Billiard M., Tafti M., 2004. Annals of Neurology, 56 (3) pp. 382-328. Peer-reviewed.
 
Association of daytime sleepiness with COMT polymorphism in patients with parkinson disease: a pilot study.
Frauscher B., Högl B., Maret S., Wolf E., Brandauer E., Wenning G.K., Kronenberg M.F., Kronenberg F., Tafti M., Poewe W., 2004. Sleep, 27 (4) pp. 733-736. Peer-reviewed.
 
Genetic regulation of sleep
Dauvilliers Y., Franken P., Tafti M., 2004. pp. 123-44 dans Luppi P.H. (eds.) Sleep: Circuits and Function chap. 7, CRC Press.
 
Genetics of delta and theta activities during sleep: Deficiency in short-chain fatty acid β-oxidation affects theta oscillations during sleep
Tafti M., Franken P., 2004., Recent Progress in Sleep Research'; one in Osaka on March 20 & 21,2003 and the other in Fukuoka on March 23, 2003 pp. S34-S35 dans Kumar V.M. (eds.) Sleep and Biological Rhythms. Peer-reviewed, Wiley.
 
Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway.
Khatami R., Maret S., Werth E., Rétey J., Schmid D., Maly F., Tafti M., Bassetti C.L., 2004. Lancet, 363 (9416) pp. 1199-1200.
 
Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset.
Dauvilliers Y., Carlander B., Rivier F., Touchon J., Tafti M., 2004. Annals of Neurology, 56 (6) pp. 905-908. Peer-reviewed.
The loss of circadian PAR bZip transcription factors results in epilepsy.
Gachon F., Fonjallaz P., Damiola F., Gos P., Kodama T., Zakany J., Duboule D., Petit B., Tafti M., Schibler U., 2004. Genes and Development, 18 (12) pp. 1397-1412. Peer-reviewed.
 
Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy.
Lecendreux M., Maret S., Bassetti C., Mouren M.C., Tafti M., 2003/12. Journal of Sleep Research, 12 (4) pp. 347-348.
 
CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.
Dauvilliers Y., Baumann C.R., Carlander B., Bischof M., Blatter T., Lecendreux M., Maly F., Besset A., Touchon J., Billiard M. et al., 2003/12. Journal of Neurology, Neurosurgery, and Psychiatry, 74 (12) pp. 1667-1673.
 
Month of birth as a risk factor for narcolepsy.
Dauvilliers Y., Carlander B., Molinari N., Desautels A., Okun M., Tafti M., Montplaisir J., Mignot E., Billiard M., 2003/09. Sleep, 26 (6) pp. 663-665.
 
Immunogenetics and sleep disorders.
Tafti M., 2003/07. Pharmacogenomics, 4 (4) pp. 365-367.
 
Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep.
Tafti M., Petit B., Chollet D., Neidhart E., de Bilbao F., Kiss J.Z., Wood P.A., Franken P., 2003. Nature Genetics, 34 (3) pp. 320-325. Peer-reviewed.
 
Genetics of sleep and sleep disorders.
Franken P., Tafti M., 2003. Frontiers in Bioscience, 8 pp. e381-e397. Peer-reviewed.
 
HLA and genetic susceptibility to sleepwalking.
Lecendreux M., Bassetti C., Dauvilliers Y., Mayer G., Neidhart E., Tafti M., 2003/01. Molecular Psychiatry, 8 (1) pp. 114-117.
 
Pharmacogenomics in the treatment of narcolepsy.
Tafti M., Dauvilliers Y., 2003/01. Pharmacogenomics, 4 (1) pp. 23-33.
 
Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses.
Dauvilliers Y., Mayer G., Lecendreux M., Neidhart E., Peraita-Adrados R., Sonka K., Billiard M., Tafti M., 2002/12. Neurology, 59 (11) pp. 1739-1745.
 
Invited review: genetic dissection of sleep.
Tafti M., Franken P., 2002/03. Journal of applied physiology, 92 (3) pp. 1339-1347. Peer-reviewed.
 
Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil.
Dauvilliers Y., Neidhart E., Billiard M., Tafti M., 2002. Pharmacogenomics Journal, 2 (1) pp. 65-68.
 
MAO-A and COMT polymorphisms and gene effects in narcolepsy.
Dauvilliers Y., Neidhart E., Lecendreux M., Billiard M., Tafti M., 2001/07. Molecular Psychiatry, 6 (4) pp. 367-372.
 
Génétique de la narcolepsie humaine [Genetics of human narcolepsy]
Dauvilliers Y., Tafti M., Billiard M., 2001. Revue Neurologique, 157 (11 Pt 2) pp. S92-S96.
 
Magnesium involvement in sleep: genetic and nutritional models.
Chollet D., Franken P., Raffin Y., Henrotte J.G., Widmer J., Malafosse A., Tafti M., 2001. Behavior Genetics, 31 (5) pp. 413-425. Peer-reviewed.
 
The homeostatic regulation of sleep need is under genetic control.
Franken P., Chollet D., Tafti M., 2001. Journal of Neuroscience, 21 (8) pp. 2610-2621.
 
Blood and brain magnesium in inbred mice and their correlation with sleep quality.
Chollet D., Franken P., Raffin Y., Malafosse A., Widmer J., Tafti M., 2000. American journal of physiology. Regulatory, integrative and comparative physiology, 279 (6) pp. R2173-R2178. Peer-reviewed.
 
The transcription factor DBP affects circadian sleep consolidation and rhythmic EEG activity.
Franken P., Lopez-Molina L., Marcacci L., Schibler U., Tafti M., 2000. Journal of Neuroscience, 20 (2) pp. 617-625.
 
Molecular approaches towards the isolation of sleep-related genes.
Schibler U., Tafti M., 1999/06. Journal of Sleep Research, 8 Suppl 1 pp. 1-10.
 
Genetic determinants of sleep regulation in inbred mice.
Franken P., Malafosse A., Tafti M., 1999. Sleep, 22 (2) pp. 155-169.
 
Lack of association between juvenile myoclonic epilepsy and HLA-DR13.
Le Hellard S., Neidhart E., Thomas P., Feingold J., Malafosse A., Tafti M., 1999/01. Epilepsia, 40 (1) pp. 117-119.
 
Quantitative trait loci approach to the genetics of sleep in recombinant inbred mice.
Tafti M., Chollet D., Valatx J.L., Franken P., 1999. Journal of Sleep Research, 8 Suppl 1 pp. 37-43.
 
Homeostatic process and sleep spindles in patients with sleep-maintenance insomnia: effect of partial (21 h) sleep deprivation.
Besset A., Villemin E., Tafti M., Billiard M., 1998/08. Electroencephalography and Clinical Neurophysiology, 107 (2) pp. 122-132.
 
Neuropharmacological characterization of basal forebrain cholinergic stimulated cataplexy in narcoleptic canines.
Reid M.S., Nishino S., Tafti M., Siegel J.M., Dement W.C., Mignot E., 1998/05. Experimental Neurology, 151 (1) pp. 89-104.
 
Genetic variation in EEG activity during sleep in inbred mice.
Franken P., Malafosse A., Tafti M., 1998. American Journal of Physiology. Regulatory Integrative and Comparative Physiology, 275 (4 Pt 2) pp. R1127-R1137.
 
Circadian distribution of rest/activity in narcoleptic and control dogs: assessment with ambulatory activity monitoring.
Nishino S., Tafti M., Sampathkumaran R., Dement W.C., Mignot E., 1997/06. Journal of Sleep Research, 6 (2) pp. 128-133.
 
Mesopontine organization of cholinergic and catecholaminergic cell groups in the normal and narcoleptic dog.
Tafti M., Nishino S., Liao W., Dement W.C., Mignot E., 1997/03. Journal of Comparative Neurology, 379 (2) pp. 185-197.
 
Localization of candidate genomic regions influencing paradoxical sleep in mice.
Tafti M., Franken P., Kitahama K., Malafosse A., Jouvet M., Valatx J.L., 1997. Neuroreport, 8 (17) pp. 3755-3758.
 
Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine.
Reid M.S., Tafti M., Nishino S., Sampathkumaran R., Siegel J.M., Mignot E., 1996/09. Brain Research, 733 (1) pp. 83-100.
 
Major histocompatibility class II molecules in the CNS: increased microglial expression at the onset of narcolepsy in canine model.
Tafti M., Nishino S., Aldrich M.S., Liao W., Dement W.C., Mignot E., 1996/08. Journal of Neuroscience, 16 (15) pp. 4588-4595.
 
Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsy.
Kanbayashi T., Nishino S., Tafti M., Hishikawa Y., Dement W.C., Mignot E., 1996/08. Neuroreport, 7 (12) pp. 1881-1886.
 
Thalidomide, immune modulation and narcolepsy.
Kanbayashi T., Nishino S., Tafti M., Hishikawa Y., Dement W.C., Mignot E., 1996/02. Sleep, 19 (2) p. 116.
 
Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy.
Nishino S., Tafti M., Reid M.S., Shelton J., Siegel J.M., Dement W.C., Mignot E., 1995/07. Journal of Neuroscience, 15 (7 Pt 1) pp. 4806-4814.
 
Effects of zolpidem on the architecture and cyclical structure of sleep in poor sleepers.
Besset A., Tafti M., Villemin E., Borderies P., Billiard M., 1995. Drugs under Experimental and Clinical Research, 21 (4) pp. 161-169.
 
Narcolepsy and immunity.
Mignot E., Tafti M., Dement W.C., Grumet F.C., 1995. Advances in Neuroimmunology, 5 (1) pp. 23-37.
 
Homeostasis and narcolepsy.
Besset A., Tafti M., Nobile L., Billiard M., 1994/12. Sleep, 17 (8 Suppl) pp. S29-S34.
 
Life events in the year preceding the onset of narcolepsy.
Orellana C., Villemin E., Tafti M., Carlander B., Besset A., Billiard M., 1994/12. Sleep, 17 (8 Suppl) pp. S50-S53.
 
Cholinergic regulation of cataplexy in canine narcolepsy in the pontine reticular formation is mediated by M2 muscarinic receptors.
Reid M.S., Tafti M., Nishino S., Siegel J.M., Dement W.C., Mignot E., 1994/08. Sleep, 17 (5) pp. 424-435.
 
Cholinergic mechanisms in canine narcolepsy--I. Modulation of cataplexy via local drug administration into the pontine reticular formation.
Reid M.S., Tafti M., Geary J.N., Nishino S., Siegel J.M., Dement W.C., Mignot E., 1994/04. Neuroscience, 59 (3) pp. 511-522.
 
Objective and subjective sleep disturbances in patients with rheumatoid arthritis. A reappraisal.
Hirsch M., Carlander B., Vergé M., Tafti M., Anaya J.M., Billiard M., Sany J., 1994/01. Arthritis and Rheumatism, 37 (1) pp. 41-49.
 
Pharyngeal CT studies in patients with mild or severe upper airway obstruction during sleep.
Polo O., Tafti M., Fraga J., Billiard M., 1993/12. Sleep, 16 (8 Suppl) pp. S152-S155.
 
Developmental regulation of carbonic anhydrase expression in mouse dorsal root ganglia.
Mayeux V., Tafti M., Baldy-Moulinier M., Valmier J., 1993/02. Brain research. Developmental brain research, 71 (2) pp. 201-208. Peer-reviewed.
 
Effets du modafinil (300 mg) sur le sommeil, la somnolence et la vigilance du narcoleptique
Besset A., Tafti M., Villemin E., Billiard M., 1993/01. Neurophysiologie clinique = Clinical neurophysiology, 23 (1) pp. 47-60. Peer-reviewed.
 
Polysomnografické nálezy u narkoleptiků stredního a vyssího vĕku
Sonka K., Tafti M., Billiard M., 1993. Sborník lékaský, 94 (4) pp. 333-344.
 
Sleep deprivation in narcoleptic subjects: effect on sleep stages and EEG power density.
Tafti M., Rondouin G., Besset A., Billiard M., 1992/12. Electroencephalography and Clinical Neurophysiology, 83 (6) pp. 339-349.
 
Sleep onset rapid-eye-movement episodes in narcolepsy: REM sleep pressure or nonREM-REM sleep dysregulation?
Tafti M., Villemin E., Carlander B., Besset A., Billiard M., 1992/12. Journal of Sleep Research, 1 (4) pp. 245-250.
 
Sleep in human narcolepsy revisited with special reference to prior wakefulness duration.
Tafti M., Villemin E., Carlander B., Besset A., Billiard M., 1992/08. Sleep, 15 (4) pp. 344-351.
 
Respiratory variation of the ballistocardiogram during increased respiratory load and voluntary central apnoea.
Polo O., Tafti M., Hämäläinen M., Vaahtoranta K., Alihanka J., 1992/02. European Respiratory Journal, 5 (2) pp. 257-262.
 
Effects of zopiclone on subjective evaluation of sleep and daytime alertness and on psychomotor and physical performance tests in athletes.
Tafti M., Besset A., Billiard M., 1992/01. Progress in Neuro-psychopharmacology and Biological Psychiatry, 16 (1) pp. 55-63.
 
Why don't all heavy snorers have obstructive sleep apnea?
Polo O.J., Tafti M., Fraga J., Porkka K.V., Déjean Y., Billiard M., 1991/06. American Review of Respiratory Disease, 143 (6) pp. 1288-1293.
 
Skeletal muscle extracts promote the survival of neurofilament-positive mammalian sensory neurons.
Valmier J., Tafti M., Baldy-Moulinier M., 1990/06. Neuroscience Letters, 114 (1) pp. 39-44.
 
Record du monde du marathon de tennis: privation de sommeil et performances
Tafti M., Vergé M., Besset A., Billiard M., 1989. Comptes rendus des séances de la Société de biologie et de ses filiales, 183 (5) pp. 474-481.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University